About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 403 record(s)
Req # A-2020-001137
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_03082752, E2B_03082374, E2B_03080761, E2B_03090273, E2B_03101501, E2B_03085974, E2B_01071214, E2B_03081015, E2B_03080531, E2B_03010448, E2B_03010606, E2B_03010611, E2B_03010640, E2B_03010818, E2B_03010836, E2B_03011738, E2B_03000192, E2B_03013094, E2B_03090446, E2B_03098040.Organization: Health Canada
August 2021
Req # A-2020-001173
Adverse Reaction Reports (AERs). Report numbers: E2B_02380323, E2B_02381051, E2B_02382135, E2B_02382919, E2B_02382952, E2B_02383044, E2B_02383050, E2B_02383448, E2B_02383461, E2B_02383631, E2B_02384641, E2B_02384644, E2B_02386322, E2B_02387443, E2B_02387511, E2B_02387512, E2B_02388725, E2B_02389318, E2B_02389609, E2B_02389651.Organization: Health Canada
August 2021
Req # A-2020-001175
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-001877-718.Organization: Health Canada
August 2021
Req # A-2020-001246
All information used by Health Canada during the approval process of Covid 19 test kit: 312730, Roche Molecular Systems, Inc (United States) Cobas SARS-CoV-2 Test. Device identifier number: 09175431190.Organization: Health Canada
August 2021
Req # A-2020-001284
Adverse Reaction Reports (AERs). Report numbers: E2B_02693359, E2B_02693390, E2B_02693699, E2B_02693798, E2B_02694233, E2B_02695474,E2B_02696267, E2B_02696541, E2B_02696542, E2B_02696556, E2B_02696557, E2B_02697431, E2B_02697833, E2B_02697847, E2B_02698311, E2B_02698313, E2B_02698395, E2B_02698889, E2B_02699029, E2B_02699032.Organization: Health Canada
August 2021
Req # A-2020-001330
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-112859-495.Organization: Health Canada
August 2021
Req # A-2020-001344
Adverse Reaction Reports (AERs) for SODIUM AUROTHIOMALATE. Report numbers: E2B_03070468, E2B_03071551, E2B_03135772.Organization: Health Canada
August 2021
Req # A-2020-001486
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-100273-135, 2020 Public Health Agency of Canada Awards Launch.Organization: Health Canada
August 2021
Req # A-2020-001524
Adverse Reaction Reports (AERs). Report numbers: E2B_03048000, E2B_03048477, E2B_03048611, E2B_03048664, E2B_03048786, E2B_03048789, E2B_03048824, E2B_03048826, E2B_03048873, E2B_03048923, E2B_03049174, E2B_03050277, E2B_03050393, E2B_03050405, E2B_03050480, E2B_03050482, E2B_03050614, E2B_03050798, E2B_03051235, E2B_03051252.Organization: Health Canada
August 2021
Req # A-2020-001551
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-116013-691, Industry Proposal for Food Advertising Restrictions to Children.Organization: Health Canada
August 2021